ME-143, a second-generation tumor-specific NADH oxidase inhibitor, exhibits efficacy by inhibiting the WNT/beta-catenin pathway in colorectal cancer cells. Demonstrating broad activity against cancers both in vitro and in vivo, this compound presents a promising therapeutic avenue.
Molecular Weight:
334.37
CAS Number:
[852536-39-1]
Formula:
C21H18O4
Target:
Endogenous Metabolite|||Others|||Wnt/beta-catenin
T73478
* VAT and and shipping costs not included. Errors and price changes excepted